PRIA funds rigorous, peer-reviewed pancreatic cancer research across the full spectrum—from basic discovery science to translational investigation and clinical research. We support early- and mid-career investigators alongside established leaders, and we engage cancer centers across the country. Our grants are selected by an independent Scientific Advisory Board.
At MSK, Pria Foundation supports the work of Dr. Vinod Balachandran and colleagues advancing our understanding of the immune system's role in pancreatic cancer—research with direct implications for new immunotherapy approaches. MSK represents one of Pria Foundation's deepest scientific partnerships and a model for what rigorous, translational investigation can achieve.
